Silicon Laboratories Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Silicon Laboratories de 91.3% y 14.4% por año respectivamente. Se prevé que el BPA crezca en un 79.3% al año. Se espera que la rentabilidad financiera sea de 12.1% en 3 años.
Información clave
91.3%
Tasa de crecimiento de los beneficios
79.31%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Semiconductor | 26.1% |
| Tasa de crecimiento de los ingresos | 14.4% |
| Rentabilidad financiera futura | 12.10% |
| Cobertura de analistas | Good |
| Última actualización | 18 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • May 06
SLAB: Higher Margin Assumptions And P E Frameworks Will Shape Future Returns
Analysts have raised their average price targets on Silicon Laboratories by double digit dollar amounts, pointing to updated assumptions around discount rates, profit margins and future P/E multiples as key drivers of the new $222.86 estimate. Analyst Commentary Across the latest research updates, bullish analysts are resetting their models on Silicon Laboratories around higher price targets, with several revisions in the $45 to $101 range that feed into the new average target of $222.86.Actualización de narrativa • Apr 20
SLAB: Merger Terms And Hold Ratings Will Guide Deal Driven Returns
Silicon Laboratories' updated analyst price targets have shifted higher by a double digit dollar amount, with many analysts pointing to refreshed views on valuation assumptions, even as recent research includes a mix of upward target revisions and downgrades to Hold. Analyst Commentary Recent Street research on Silicon Laboratories has been active, with several firms adjusting price targets and others moving to Hold ratings.Actualización de narrativa • Apr 04
SLAB: Merger Terms And Mixed Ratings Will Shape Deal Driven Return Profile
Silicon Laboratories' analyst price targets have shifted higher by double-digit dollar amounts, reaching up to $101, as analysts recalibrate their views using updated assumptions for profit margins, discount rates, and future P/E multiples. Analyst Commentary Recent Street research on Silicon Laboratories shows a wide range of views, with some analysts lifting price targets by double digit dollar amounts and others moving to more neutral stances.Actualización de narrativa • Mar 20
SLAB: Deal Terms And Mixed Ratings Will Shape Merger Driven Return Profile
Silicon Laboratories' updated analyst price target has shifted in line with modest tweaks to the discount rate, profit margin and future P/E assumptions, as analysts weigh a mix of recent target hikes from $45 to $101 alongside several fresh downgrades to Hold. Analyst Commentary Street research on Silicon Laboratories has recently clustered around two camps, with some raising price targets by sizeable dollar amounts and others shifting to Hold.Actualización de narrativa • Mar 05
SLAB: Deal Terms And Mixed Ratings Will Guide Future Return Profile
Silicon Laboratories' analyst price targets have moved higher by a wide range, with several firms lifting their views by $45 to $101 as analysts reassessed the company using slightly adjusted discount rate, profit margin and P/E assumptions. Analyst Commentary Recent research on Silicon Laboratories presents a mixed picture, with some firms lifting price targets by wide margins and others moving to the sidelines.Actualización de narrativa • Feb 19
SLAB: Deal Terms And Mixed Ratings Will Shape Future Upside Potential
Analysts have lifted their Silicon Laboratories fair value estimate from $164.13 to about $222.86, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that better reflect recent Street research on the name. Analyst Commentary Recent Street research on Silicon Laboratories is mixed, with several firms lifting price targets while others move to more neutral stances.Seeking Alpha • Feb 05
Silicon Labs Acquisition Is A Quiet Win For Texas Instruments
Summary Silicon Labs (SLAB) is being acquired by Texas Instruments (TXN) for $231/share in an all-cash deal, a 50% premium. The $7.5B acquisition price represents 9.55x trailing revenue and 78x trailing operating free cash flow, a strong outcome for SLAB shareholders. TXN expects $450M in annual synergies within three years, transforming SLAB from loss-making to meaningfully profitable under its umbrella. Both SLAB and TXN are rated hold; the deal is positive but current arbitrage and entry points are not compelling. Read the full article on Seeking AlphaActualización de narrativa • Feb 05
SLAB: Downgrades And Deal Uncertainty Will Cap Upside Potential
The updated analyst price target for Silicon Laboratories moves from US$150.44 to US$164.13, with analysts pointing to revised profit margin assumptions and a lower projected future P/E multiple, even as several firms have shifted to more neutral or Hold ratings following recent deal commentary. Analyst Commentary Recent research updates cluster around a more cautious stance, with several firms shifting to Hold or neutral views following deal related headlines.
Nueva narrativa • Feb 05
Smart Meter And Industrial IoT Tailwinds Will Fail To Support Current Expectations
Catalysts About Silicon Laboratories Silicon Laboratories develops mixed signal wireless chips and software for Internet of Things applications across industrial, commercial, smart home and medical end markets. What are the underlying business or industry changes driving this perspective?Artículo de análisis • Jul 03
Revenues Not Telling The Story For Silicon Laboratories Inc. (NASDAQ:SLAB) After Shares Rise 25%
Silicon Laboratories Inc. ( NASDAQ:SLAB ) shares have continued their recent momentum with a 25% gain in the last month...Nueva narrativa • May 26
Smart Home Demand And IoT Trends Will Unlock Value
Accelerated adoption of diverse IoT applications and next-generation products is driving higher customer demand and expanded growth opportunities across new and existing segments.Seeking Alpha • Feb 09
Silicon Laboratories: Rating Upgrade As Q4 2024 Results Are More Bullish On Outlook
Summary Upgraded Silicon Laboratories stock to strong buy due to robust 4Q24 results, confirming a bullish growth outlook, with 91% y/y revenue growth and strong segment performance. Management's 1Q25 guidance indicates accelerating growth, with 7% sequential and 67% y/y revenue growth, surpassing seasonal trends and suggesting a strong year ahead. SLAB's CGM and ESL businesses are ramping up faster than expected, validating product effectiveness and presenting significant multi-year growth opportunities. Valuation remains attractive at ~6x forward sales, with potential for re-rating towards previous highs, offering substantial upside for long-term investors. Read the full article on Seeking AlphaSeeking Alpha • Jan 21
Silicon Laboratories: The Timing To Growth Inflection Is Within Sight
Summary I recommend a buy rating for Silicon Laboratories stock due to expected strong y/y revenue growth starting in FY25, driven by AI advancements and data center investments. SLAB's efficient wireless SoCs and AI integration position it to benefit from the growing AI market. Despite recent sequential revenue growth, the market hasn't fully priced in SLAB's potential. Risks include uncertain demand recovery in industrial markets and potential impacts from rising interest rates and geopolitical tensions. Read the full article on Seeking AlphaSeeking Alpha • Nov 05
A Slower, More Stretched-Out Recovery Has Weighed On Silicon Labs
Summary Silicon Labs has underperformed the S&P 500 but fared better than many semiconductor peers, despite weak demand in major end-markets. Q3’24 results were in line with expectations, showing a double-digit year-over-year revenue decline but sequential improvement. Long-term growth opportunities in IoT markets like smart home, retail, smart metering, and glucose monitoring remain meaningful, despite current demand challenges and though guidance for Q4’24 remains soft. I've reduced my near-term fair value estimate to $115 on a slower recovery trajectory, but the potential for $130+ remains when revenue and margins recover. Read the full article on Seeking AlphaSeeking Alpha • Oct 17
Silicon Laboratories: A Questionable Outlook Offsets Improving Results
Summary Silicon Laboratories has recouped some of the losses for the year, with the stock moving higher, but there are a few reasons why further stock gains may have to wait. The excess inventory problem is getting better with the quarterly numbers rebounding, but the outlook beyond is nonetheless hazy. A continued rally in the stock requires strong growth, but it is unclear what demand and thus growth will be like without excess inventory. SLAB can move past present hurdles, but it will need to provide some answers to pressing questions, which it has not done yet. Read the full article on Seeking AlphaSeeking Alpha • Jul 31
Silicon Laboratories: Equity Story Remains Very Attractive
Summary SLAB recommended as a buy with visible recovery growth and margin expansion potential. Positive earnings report with strong sequential revenue growth and margin expansion. Growth catalyst that could potentially drive higher growth is the AI/ML opportunities. Read the full article on Seeking AlphaSeeking Alpha • Jul 14
Silicon Labs Ready For The Next IoT-Fueled Run
Summary After a 70% peak-to-trough revenue decline, Silicon Labs is stabilizing, with promising prospects in Bluetooth and WiFi markets and AI edge deployments ready to drive the next up-cycle. Following sequential growth in Q1'24, SLAB should deliver 30%-plus sequential growth in Q2'24, driven by consumer/home market restocking and new wins, including glucose monitoring. Silicon Labs’ new Series 3 chips, with significantly greater compute capacity over Series 2, position the company well for industrial AI edge installations, enhancing its competitiveness in the IoT sector. With expanding addressable market opportunities, share gains, and new product launches, SLAB could achieve mid-teens revenue growth and mid-to-high teens operating margins in three years, driving a fair value of $130-$150. Read the full article on Seeking AlphaSeeking Alpha • May 05
Silicon Laboratories: An Uncertain Recovery Outlook Continues To Linger
Summary Silicon Laboratories released a mixed report on the 24th by surpassing quarterly estimates and falling short on guidance, resulting in a drop in the stock. SLAB is making progress regarding the inventory problem, but SLAB acknowledges the problem has yet to be resolved. The latest Investor Presentation laid out ambitious targets, which paint a rosy picture for the future, but which may be overly aggressive. SLAB is recovering, but it is too early to say SLAB is out of the woods, especially given the recent weakness in the stock. Read the full article on Seeking AlphaPrevisiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 1,218 | N/A | N/A | N/A | 1 |
| 12/31/2027 | 1,071 | -1 | 123 | 129 | 7 |
| 12/31/2026 | 923 | -44 | 11 | 43 | 7 |
| 4/4/2026 | 821 | -50 | 18 | 53 | N/A |
| 1/3/2026 | 785 | -65 | 66 | 96 | N/A |
| 10/4/2025 | 743 | -86 | 74 | 97 | N/A |
| 7/5/2025 | 703 | -105 | 75 | 95 | N/A |
| 4/5/2025 | 656 | -165 | 91 | 106 | N/A |
| 12/28/2024 | 584 | -191 | -26 | -14 | N/A |
| 9/28/2024 | 505 | -237 | -17 | -6 | N/A |
| 6/29/2024 | 542 | -198 | -85 | -71 | N/A |
| 3/30/2024 | 642 | -105 | -106 | -89 | N/A |
| 12/30/2023 | 782 | -35 | -53 | -30 | N/A |
| 9/30/2023 | 953 | 61 | -60 | -35 | N/A |
| 7/1/2023 | 1,019 | 71 | -16 | 12 | N/A |
| 4/1/2023 | 1,037 | 82 | -46 | -17 | N/A |
| 12/31/2022 | 1,024 | 91 | 45 | 72 | N/A |
| 10/1/2022 | 975 | 72 | -190 | -160 | N/A |
| 7/2/2022 | 890 | 31 | -164 | -134 | N/A |
| 4/2/2022 | 797 | -10 | -67 | -40 | N/A |
| 1/1/2022 | 721 | -58 | -129 | -100 | N/A |
| 10/2/2021 | 658 | -85 | 103 | 127 | N/A |
| 7/3/2021 | 606 | -92 | 94 | 114 | N/A |
| 4/3/2021 | 551 | -109 | 71 | 91 | N/A |
| 1/2/2021 | 511 | -115 | 118 | 136 | N/A |
| 10/3/2020 | 585 | -84 | 142 | 159 | N/A |
| 7/4/2020 | 675 | -38 | 180 | 196 | N/A |
| 4/4/2020 | 767 | -18 | 178 | 194 | N/A |
| 12/28/2019 | 474 | -103 | N/A | 167 | N/A |
| 9/28/2019 | 834 | 25 | N/A | 163 | N/A |
| 6/29/2019 | 841 | 32 | N/A | 194 | N/A |
| 3/30/2019 | 851 | 63 | N/A | 183 | N/A |
| 12/29/2018 | 868 | 84 | N/A | 174 | N/A |
| 9/29/2018 | 854 | 64 | N/A | 193 | N/A |
| 6/30/2018 | 822 | 56 | N/A | 160 | N/A |
| 3/31/2018 | 795 | 58 | N/A | 170 | N/A |
| 12/30/2017 | 769 | 47 | N/A | 190 | N/A |
| 9/30/2017 | 750 | 72 | N/A | 164 | N/A |
| 7/1/2017 | 730 | 72 | N/A | 149 | N/A |
| 4/1/2017 | 715 | 71 | N/A | 129 | N/A |
| 12/31/2016 | 698 | 61 | N/A | 129 | N/A |
| 10/1/2016 | 675 | 47 | N/A | 125 | N/A |
| 7/2/2016 | 653 | 37 | N/A | 129 | N/A |
| 4/2/2016 | 643 | 29 | N/A | 124 | N/A |
| 1/2/2016 | 645 | 30 | N/A | 105 | N/A |
| 10/3/2015 | 647 | 34 | N/A | 117 | N/A |
| 7/4/2015 | 649 | 30 | N/A | 111 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que SLAB siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que SLAB siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que SLAB siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (14.4% al año) de SLAB crezcan más rápidamente que los del mercado US (11.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 14.4% al año) de SLAB crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de SLAB sea baja dentro de 3 años (12.1%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/01 06:30 |
| Precio de las acciones al final del día | 2026/05/29 00:00 |
| Beneficios | 2026/04/04 |
| Ingresos anuales | 2026/01/03 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Silicon Laboratories Inc. está cubierta por 28 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Thomas O'Malley | Barclays |
| Christopher Muse | Barclays |
| Gary Mobley | Benchmark Company |